NeuroSense Therapeutics Ltd.
- Last sale
- Nov 12, 2026 · +4.65%
- Market cap
- $58.60M
- 32.56M shares
- Filings
- 314
—
—
—FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−95.1% FY25 yoy
- $58.60M
- —
- —
- —
- -13.10%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Gross Profit
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | $310.00K | — | $310.00K | — | 15.38M sh | — | — |
| FY2022 | $310.00K | — | $310.00K | — | — | — | — |
| FY2021 | $29.00K | — | $29.00K | — | 10.94M sh | — | — |
| FY2020 | $28.00K | — | $28.00K | — | — | — | — |
| FY2019 | $27.00K | — | $27.00K | — | — | — | — |
Pharmaceutical preparations
NeuroSense Therapeutics Ltd. is the 323rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ACRVAcrivon Therapeutics, Inc.———$61.9MXBITXBiotech Inc.———$60.1MCLNNClene Inc.$200.0K41.5%13,086.5%$59.8MNMADNomad Power Solutions, Inc.———$59.7M
NRSNNeuroSense Therapeutics Ltd. (this company)———$58.6M
XLOXilio Therapeutics, Inc.$43.8M589.9%80.1%$58.3MSPROSpero Therapeutics, Inc.———$58.1MRFLRafael Holdings, Inc.$874.0K4.7%3,390.7%$57.9MBOLDBoundless Bio, Inc.———$57.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
NeuroSense Therapeutics Ltd. · CIK 1875091 · Engraved from SEC EDGAR